|
Q3 2025
|
5 |
166,054 |
OMADA HEALTH INC, ZBIO, MBX, TALK
|
13F-HR
|
11/14/2025 |
000154569225000005 |
|
Q2 2025
|
7 |
184,154 |
DAVE, OMADA HEALTH INC, TALK, MBX
|
13F-HR
|
8/14/2025 |
000141588925021886 |
|
Q1 2025
|
6 |
112,176 |
DAVE, TALK, MBX, ZBIO
|
13F-HR
|
5/12/2025 |
000141588925012671 |
|
Q4 2024
|
7 |
186,937 |
DAVE, TALK, MBX, UDMY
|
13F-HR
|
2/10/2025 |
000110465925010945 |
|
Q3 2024
|
8 |
176,148 |
MBX BIOSCIENCES INC, ZENAS BIOPHARMA INC, TALK, DAVE
|
13F-HR
|
11/12/2024 |
000110465924116813 |
|
Q2 2024
|
6 |
91,271 |
TALK, UDMY, DAVE, OPEN
|
13F-HR
|
8/13/2024 |
000110465924088976 |
|
Q1 2024
|
6 |
125,942 |
TALK, UDMY, DAVE, OPEN
|
13F-HR
|
5/10/2024 |
000110465924059924 |
|
Q4 2023
|
6 |
112,095 |
UDMY, TALK, OPEN, GROV
|
13F-HR
|
2/14/2024 |
000110465924023698 |
|
Q3 2023
|
8 |
111,700 |
UDMY, TALK, OPEN, GROV
|
13F-HR
|
11/8/2023 |
000110465923115739 |
|
Q2 2023
|
9 |
114,648 |
UDMY, TALK, OPEN, GROV
|
13F-HR
|
8/1/2023 |
000110465923086375 |
|
Q1 2023
|
8 |
86,931 |
UDMY, TALK, OPEN, GROV
|
13F-HR
|
5/15/2023 |
000110465923060795 |
|
Q4 2022
|
8 |
102,461 |
UDMY, IMPL, TALK, GROV
|
13F-HR
|
2/14/2023 |
000110465923020374 |